Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Desoxyepothilones B and F promising new cancer therapeutics

Aug. 2, 2001

Thalidomide improves survival in multiple myeloma patients

Aug. 1, 2001

Phase II trial of E21R for acute myeloid leukemia to start

July 31, 2001

Pegylated formulations of rHuTNF-alpha with improved properties prepared in China

July 30, 2001

FLT3 tyrosine kinase inhibitor exerts specific cytotoxicity against certain mutated AML blasts

July 30, 2001

Ilex enters into worldwide license agreement for MUC1 technology

July 30, 2001

Positive opinion from EMEA moves Foscan closer to approval

July 30, 2001

Abbott patents new series of peptide angiogenesis inhibitors

July 27, 2001

CancerVax to seek marketing approval of Canvaxin melanoma vaccine in Canada

July 27, 2001

Thalomid to be submitted for new indication this year

July 27, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.